Funding allocated to our team will be used to investigate the interplay between bovine airway cells and bovine alphaherpesvirus-1 (BoHV-1), aiming to understand pathogenic mechanisms and to design prophylactic or therapeutic interventions to prevent infectious bovine rhinotracheitis and BRD.
This summer, we welcomed three new members: Taylor, Carter and Dr. Khan! Pictured here in that order from left to right. Check our "People" page to learn more about them.
The latest issue of the Nanovaccine Institute's quarterly Newsletter covered the publication of our recent original article in Acta Biomaterialia. The data included in this study were generated during Dr.